15.80Open15.80Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover170.41%IV-10.03%PremiumDec 20, 2024Expiry Date17.55Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9283Delta0.0205Gamma0.99Leverage Ratio-0.0195Theta-0.0121Rho-0.91Eff Leverage0.0059Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet